Results 151 to 159 of about 86,503 (159)

Severe Vincristine-induced Neuropathic Pain in a CYP3A5 Nonexpressor With Reduced CYP3A4/5 Activity: Case Study

Clinical Therapeutics, 2016
Kuntheavy Ing Lorenzini, Monica Escher, Youssef Daali   +2 more
exaly  

Vincristine Pharmacokinetics Pathway And Neurotoxicity During Early Phases Of Treatment in Pediatric Acute Lymphoblastic Leukemia

Pharmacogenomics, 2016
Idoia Martin-Guerrero, Itziar Astigarraga, Elixabet Lopez-Lopez   +2 more
exaly  

Preclinical pharmacology, toxicology and efficacy of sphingomyelin/cholesterol liposomal vincristine for therapeutic treatment of cancer

Cancer Chemotherapy and Pharmacology, 1998
Marcel B Bally, Karen A Gelmon, Lawrence Mayer   +2 more
exaly  

Profound destructive effects of adolescent exposure to vincristine accompanied with some sex differences in motor and memory performance

Canadian Journal of Physiology and Pharmacology, 2012
Nader Shahrokhi, Mohammad Shabani
exaly  

Sphingomyelin/cholesterol liposomal vincristine: a new formulation for an old drug

Expert Opinion on Biological Therapy, 2006
Jane Winter
exaly  

Vincristine sulfate liposomes injection (Marqibo) in heavily pretreated patients with refractory aggressive non-Hodgkin lymphoma†

Cancer, 2009
Jane Winter, Robert Pytlík, Randy D Gascoyne   +2 more
exaly  

Vincristine-induced peripheral neuropathy in children with cancer: A systematic review

Critical Reviews in Oncology/Hematology, 2017
Gertjan Kaspers, Johannes C.F. Ket, Floor Abbink   +2 more
exaly  

Vincristine attenuates doxorubicin cardiotoxicity

Biochemical and Biophysical Research Communications, 2008
Jianqing Zhang, Norman Honbo
exaly  

Vincristine pharmacokinetics and response to vincristine monotherapy in an up-front window study of the Dutch Childhood Leukaemia Study Group (DCLSG)

European Journal of Cancer, 2005
exaly